Maravai LifeSciences Holdings, Inc.Maravai LifeSciences Holdings, Inc.Maravai LifeSciences Holdings, Inc.

Maravai LifeSciences Holdings, Inc.

No trades
See on Supercharts
Market capitalization
‪1.94 B‬USD
−0.90USD
‪−119.03 M‬USD
‪288.95 M‬USD
‪106.83 M‬
Beta (1Y)
2.02

About Maravai LifeSciences Holdings, Inc.

CEO
William Martin
Headquarters
San Diego
Employees (FY)
650
Founded
2014
FIGI
BBG00Y1DFV91
Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MRVI is 7.67 USD — it has decreased by 0.65% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Maravai LifeSciences Holdings, Inc. stocks are traded under the ticker MRVI.
Maravai LifeSciences Holdings, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
MRVI stock is 4.74% volatile and has beta coefficient of 2.02. Check out the list of the most volatile stocks — is Maravai LifeSciences Holdings, Inc. there?
MRVI earnings for the last quarter are −0.01 USD per share, whereas the estimation was 0.01 USD resulting in a −280.12% surprise. The estimated earnings for the next quarter are −0.01 USD per share. See more details about Maravai LifeSciences Holdings, Inc. earnings.
Maravai LifeSciences Holdings, Inc. revenue for the last quarter amounts to ‪66.86 M‬ USD despite the estimated figure of ‪75.47 M‬ USD. In the next quarter revenue is expected to reach ‪64.37 M‬ USD.
Yes, you can track Maravai LifeSciences Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
MRVI stock has fallen by 6.35% compared to the previous week, the month change is a 11.84% fall, over the last year Maravai LifeSciences Holdings, Inc. has showed a 46.06% decrease.
MRVI net income for the last quarter is ‪−105.96 M‬ USD, while the quarter before that showed ‪−6.46 M‬ USD of net income which accounts for ‪−1.54 K‬% change. Track more Maravai LifeSciences Holdings, Inc. financial stats to get the full picture.
Today Maravai LifeSciences Holdings, Inc. has the market capitalization of ‪1.02 B‬, it has decreased by 9.46% over the last week.
No, MRVI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MRVI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Maravai LifeSciences Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
MRVI reached its all-time high on Aug 23, 2021 with the price of 63.55 USD, and its all-time low was 4.52 USD and was reached on Nov 9, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 650.00 employees. See our rating of the largest employees — is Maravai LifeSciences Holdings, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Maravai LifeSciences Holdings, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Maravai LifeSciences Holdings, Inc. stock shows the sell signal. See more of Maravai LifeSciences Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Maravai LifeSciences Holdings, Inc. future price: according to them, MRVI price has a max estimate of 15.00 USD and a min estimate of 6.50 USD. Read a more detailed Maravai LifeSciences Holdings, Inc. forecast: see what analysts think of Maravai LifeSciences Holdings, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Maravai LifeSciences Holdings, Inc. EBITDA is ‪41.57 M‬ USD, and current EBITDA margin is 15.43%. See more stats in Maravai LifeSciences Holdings, Inc. financial statements.